BVF INC/IL - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 54 filers reported holding X4 PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
BVF INC/IL ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1,338,216
-7.7%
1,347,650
+58.9%
0.06%
-6.7%
Q3 2022$1,450,000
+77.3%
847,8790.0%0.06%
+50.0%
Q2 2022$818,000
-44.9%
847,8790.0%0.04%
-32.2%
Q1 2022$1,484,000
-23.6%
847,8790.0%0.06%
-15.7%
Q4 2021$1,942,000
-56.7%
847,8790.0%0.07%
-60.0%
Q3 2021$4,485,000
-18.6%
847,8790.0%0.18%
-15.5%
Q2 2021$5,511,000
-41.4%
847,879
-22.3%
0.21%
-41.2%
Q1 2021$9,398,000
+84.3%
1,091,579
+37.7%
0.35%
+75.1%
Q4 2020$5,098,000
-5.0%
792,8920.0%0.20%
-31.2%
Q3 2020$5,368,000
-43.0%
792,892
-21.6%
0.29%
-49.7%
Q2 2020$9,422,000
-19.6%
1,010,892
-13.7%
0.58%
-46.8%
Q1 2020$11,717,000
-4.1%
1,171,728
+2.6%
1.09%
+17.9%
Q4 2019$12,219,000
+62.0%
1,141,974
+92.4%
0.93%
+16.8%
Q3 2019$7,543,000
-13.4%
593,474
+2.2%
0.79%
-16.6%
Q2 2019$8,708,000580,5000.95%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tri Locum Partners LP 6,247,500$6,809,7752.18%
Bain Capital Life Sciences Investors, LLC 15,960,588$17,397,0411.94%
Stonepine Capital Management, LLC 5,273,685$5,748,3171.91%
NEA Management Company, LLC 14,986,793$16,335,6041.26%
Sio Capital Management, LLC 2,599,003$2,832,9130.88%
New Leaf Venture Partners, L.L.C. 335,000$365,1500.47%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,973,683$2,151,3140.25%
Monashee Investment Management LLC 427,265$465,7190.20%
Orbimed Advisors 7,133,515$7,775,5310.16%
Parkman Healthcare Partners LLC 800,000$872,0000.16%
View complete list of X4 PHARMACEUTICALS INC shareholders